| 舒利迭治疗慢性阻塞性肺疾病临床疗效观察 |
| |
| 引用本文： | 郑荣. 舒利迭治疗慢性阻塞性肺疾病临床疗效观察[J]. 黑龙江医学, 2011, 35(1): 33-34. DOI: 10.3969/j.issn.1004-5775.2011.01.012 |
| |
| 作者姓名： | 郑荣 |
| |
| 作者单位： | 云南省交通中心医院内一科,云南,昆明,650106 |
| |
| 摘 要： | 目的 研究舒利迭( 沙美特罗/丙酸氟替卡松)治疗慢性阻塞性肺疾病(COPD)的疗效.方法 对 98例确诊为 COPD 的患者随机分成两组,两组均予常规治疗,实验组加用舒利迭(沙美特罗/丙酸氟替卡松,50 μg∕500 μg)吸入,1次/d,两组均于治疗前后测定肺功能指标 FEV1、FEV1 /FVC 及 FEV1 占预...
|
| 关 键 词： | 慢性阻塞性肺疾病 舒利迭 肺功能 临床疗效 |
Seretide Treatment of Chronic Obstructive Pulmonary Disease Clinical Observation |
| |
| ZHENG Rong. Seretide Treatment of Chronic Obstructive Pulmonary Disease Clinical Observation[J]. Heilongjiang Medical Journal, 2011, 35(1): 33-34. DOI: 10.3969/j.issn.1004-5775.2011.01.012 |
| |
| Authors: | ZHENG Rong |
| |
| Affiliation: | ZHENG Rong(Traffic Central Hospital of Yunnan Province,Kunming 650106,CHINA) |
| |
| Abstract: | Objective To investigate an effective treatment for chronic obstructive pulmonary disease(COPD).Methods 98 patients with COPD were randomly divided into two groups,the experiental group and the control group.Patients in the experiental group were given seretide 50 μg/500 μg inhalation once a day and the control group received the inhalation of beclomethasone 50 μg twice a day and the salbutamol aerosol was used once in need.Before and after treatment,thepulmonary functionincluding FEV1,FEV1/FVC and FEV1/predictive value was tested and then the pulmonary functional changes before and after therapy were evaluated.Results In the experimental group,clinical sympton integral and FEV1,FEV1/FVC and FEV1/predictive value were all increased,compared to those before treatment,there were statistically signipicant differences,P<0.05.Conclusion Seretide can presently serve as the most ideal medicine for COPD due to its more significant curative effect than that of the single composition or the other compound prepara-tion. |
| |
| Keywords: | Chronic obstructive pulmonary diseases(COPD) Seretide Lung function Clinical curative effect |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
